Catsci Ltd

Medicines manufacturing involves complex processes that are often hindered by inefficiencies and human errors, leading to wasted time, resources, and increased costs. Traditional systems, such as electronic lab notebooks (ELNs) and laboratory information management systems (LIMS), do not fully capture or automate key steps in these processes, especially d...

Laboratory work is notoriously difficult to replicate. This happens for many different reasons. Small changes in conditions can affect reaction progress; individuals all carry out processes in very slightly different ways and many observations and measurements can be subjective. Reach help control the variability commonly seen in laboratory work through o...

A consortium comprising Shasun, Prozomix and CatScI has been established as part of the Innovate UK’s IB Catalyst. The key goal of the project is to develop a novel IB route to a nutraceutical that is currently manufactured through traditional chemical manufacturing techniques or isolated from scarce natural resources. The new technology has the potential...

A consortium comprising of Prozomix, CatScI Ltd and Charnwood Technical Consulting has been established as part of the Innovate UK’s IB Catalyst. The key goal of the project is to develop a technology platform for an IB route to active pharmaceutical ingredients to replace current processes manufactured through traditional chemical manufacturing technique...

A consortium comprising of Aesica Pharmaceuticals, Biocatalysts Ltd, CatScI Ltd and Charnwood Technical Consulting has been established as part of the Sustainable High-Value Chemical Manufacture through Industrial Biotechnology (IB) 2 competition from the TSB. The key goal of the project is to identify novel IB routes to an active pharmaceutical ingredien...

Chemical processes catalysed with Palladium (Pd) compounds, and based on Nobel-prize winning methods, have become essential for the production of life-enhancing pharmaceuticals & chemicals. These processes underpin global manufacturing worth more than £10billion each year for pharmaceuticals alone. However, the components of the Pd-catalyst must be recove...

Two areas of great unmet medical need are oncology and anti-infectives. The dawn of the area of personalised medicine for treating cancer and the increasing rise of resistance in many infective diease types means we urgently need many new drugs active in these areas. This project seeks to exploite the discovery of a novel catalytic reaction shown by a com...